MTIP (Group)

https://www.mtip.ch

LinkedIn: https://www.linkedin.com/company/mtip-healthtech-investors

MTIP is a leading Swiss-based growth equity firm investing in European healthtech companies that aim to revolutionize global healthcare. We leverage our deep sector expertise to help the founders scale up successful and sustainable digital health businesses. At MTIP, we are driven by the purpose to empower healthtech innovation with a potential to transform lives and make a meaningful impact on the world. *

	Start	2014-11-11 established
	Today	MTIP AG
	Predecessor	MTIP MedTech Innovation Partners AG
	Industry	fund, human health
	Industry 2	MedTech (medical technology)
	Person	Kausch, Christoph (MTIP MedTech Innovation Partners AG 201704 CEO)

	Region	Basel BS
	Country	Switzerland
	Street	35 Rittergasse
	City	4051 Basel
	Tel	+41-61-551-0250
		Address record changed: 2024-02-20

Basic data	Employees	n. a.
	Currency	CHF
	Annual sales	60,000,000 (fund size at closing (2017) 2017-03-31)

		* Document for »About Section«: MTIP AG. (2/14/24). "Press Release: MTIP Invests $15 Million in Caresyntax".

		Record changed: 2024-02-20

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

More documents for MTIP (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)